472 related articles for article (PubMed ID: 20889005)
1. [Microbiota and irritable bowel syndrome].
Ducrotté P
Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S52-6. PubMed ID: 20889005
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
Parkes GC; Brostoff J; Whelan K; Sanderson JD
Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
[TBL] [Abstract][Full Text] [Related]
3. [Postinfectious irritable bowel syndrome].
Döbrönte Z; Lakner L; Sarang K
Orv Hetil; 2006 Oct; 147(43):2077-80. PubMed ID: 17297754
[TBL] [Abstract][Full Text] [Related]
4. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.
Parkes GC; Rayment NB; Hudspith BN; Petrovska L; Lomer MC; Brostoff J; Whelan K; Sanderson JD
Neurogastroenterol Motil; 2012 Jan; 24(1):31-9. PubMed ID: 22070725
[TBL] [Abstract][Full Text] [Related]
5. Altered intestinal microbiota in irritable bowel syndrome.
Lee KJ; Tack J
Neurogastroenterol Motil; 2010 May; 22(5):493-8. PubMed ID: 20414959
[TBL] [Abstract][Full Text] [Related]
6. Bacterial concepts in irritable bowel syndrome.
Lin HC; Pimentel M
Rev Gastroenterol Disord; 2005; 5 Suppl 3():S3-9. PubMed ID: 17713456
[TBL] [Abstract][Full Text] [Related]
7. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
[TBL] [Abstract][Full Text] [Related]
8. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
9. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
[TBL] [Abstract][Full Text] [Related]
10. Bacterial overgrowth as a cause of irritable bowel syndrome.
Riordan SM; Kim R
Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role.
Bolino CM; Bercik P
Infect Dis Clin North Am; 2010 Dec; 24(4):961-75, ix. PubMed ID: 20937460
[TBL] [Abstract][Full Text] [Related]
12. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.
Crouzet L; Gaultier E; Del'Homme C; Cartier C; Delmas E; Dapoigny M; Fioramonti J; Bernalier-Donadille A
Neurogastroenterol Motil; 2013 Apr; 25(4):e272-82. PubMed ID: 23433203
[TBL] [Abstract][Full Text] [Related]
13. A role for the gut microbiota in IBS.
Collins SM
Nat Rev Gastroenterol Hepatol; 2014 Aug; 11(8):497-505. PubMed ID: 24751910
[TBL] [Abstract][Full Text] [Related]
14. Treating irritable bowel syndrome with probiotics: the evidence.
Parkes GC; Sanderson JD; Whelan K
Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
[TBL] [Abstract][Full Text] [Related]
15. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.
Spiegel BM
Clin Gastroenterol Hepatol; 2011 Jun; 9(6):461-9; quiz e59. PubMed ID: 21397724
[TBL] [Abstract][Full Text] [Related]
16. Alterations in intestinal microbial flora and human disease.
Othman M; Agüero R; Lin HC
Curr Opin Gastroenterol; 2008 Jan; 24(1):11-6. PubMed ID: 18043226
[TBL] [Abstract][Full Text] [Related]
17. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
Quigley EM
J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128
[TBL] [Abstract][Full Text] [Related]
18. [Irritable bowel syndrome: a functional disorder?].
Man F; Bustos Fernández LM
Acta Gastroenterol Latinoam; 2013 Dec; 43(4):321-34. PubMed ID: 24516961
[TBL] [Abstract][Full Text] [Related]
19. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A
Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
[TBL] [Abstract][Full Text] [Related]
20. Irritable bowel syndrome and small intestinal bacterial overgrowth.
Yamini D; Pimentel M
J Clin Gastroenterol; 2010; 44(10):672-5. PubMed ID: 20838236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
